A Phase I Feasibility Study Assessing the Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 17 Apr 2015
At a glance
- Drugs Clofarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 11 Apr 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 Aug 2010 Planned end date changed from 1 Apr 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 05 Aug 2010 Planned initiation date changed from 1 Apr 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.